Ampio Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ampio Pharmaceuticals Inc AMPE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0886 9.41% 1.03 19:54:00
Close Price Low Price High Price Open Price Previous Close
1.08 1.03 1.39 1.28 0.9414
more quote information »

Recent News

Date Time Source Heading
9/21/20208:03IHNWFeaturedMicron Waste's Subsidiary starts to Manufacture Made in Canada Face Masks pursuant to its Medical Device Establishment License
9/21/202012:32IHNWFeaturedIdeanomics is Empowering the Electric Vehicle-Driven Economy
9/21/202009:15PRNUSFDA Grants IND and Approves Clinical Trial Protocol of..
9/14/202009:15PRNUSAmpion Phase I COVID-19 Patient Trial Results Featured on..
9/09/202009:15PRNUSAmpio Reports Positive Results for Ampion Treatment in..
9/04/202009:15PRNUSAmpio Announces Enrollment Completion for Intravenous ("IV")..
9/02/202016:05EDGARCurrent Report Filing (8-k)
8/19/202008:00PRNUSAmpio Provides Update on COVID-19 Clinical Trial Activities
7/31/202008:47EDGARQuarterly Report (10-q)
7/23/202008:00PRNUSAmpio Starts Patient Enrollment in its Ampion COVID-19..
7/20/202008:00PRNUSAmpio Reports a Publication on the Potential Benefits of..
7/14/202016:01EDGARCurrent Report Filing (8-k)
7/06/202016:58EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
7/06/202014:32EDGARStatement of Changes in Beneficial Ownership (4)
6/19/202008:16EDGARCurrent Report Filing (8-k)
6/19/202008:00PRNUSAmpio to Start First Clinical Trial in COVID-19 Program
5/22/202008:00PRNUSAmpio Provides Update on COVID-19 Program
5/11/202008:00PRNUSAmpio Reports Acceptance of Publication on the Potential..
5/07/202006:01EDGARNotice of Effectiveness (effect)
5/06/202017:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/06/202017:08EDGARQuarterly Report (10-q)
4/30/202017:03EDGARSecurities Registration Statement (simplified Form) (s-3/a)
4/22/202016:03EDGARCurrent Report Filing (8-k)
4/16/202017:19EDGARSecurities Registration Statement (simplified Form) (s-3)
4/16/202016:02EDGARCurrent Report Filing (8-k)
4/02/202009:00PRNUSAmpio Pharmaceutical's Application to the FDA for a Clinical..
3/24/202008:33EDGARCurrent Report Filing (8-k)
3/24/202007:00PRNUSAmpio Suspends Patient Enrollment in its Phase 3 Study of..
3/24/202006:30PRNUSAmpio is Preparing an Expanded Access FDA protocol to Study..
2/21/202007:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/21/202006:30PRNUSAmpio Provides Corporate Update
2/21/202006:15EDGARAnnual Report (10-k)
2/20/202016:18EDGARCurrent Report Filing (8-k)
12/04/201908:30PRNUSAmpio Provides Update on AP-013 Phase III Clinical Trial and..
11/07/201916:34EDGARQuarterly Report (10-q)
10/31/201916:31EDGARProxy Statement (definitive) (def 14a)
10/29/201906:03EDGARCurrent Report Filing (8-k)
10/21/201916:36EDGARStatement of Changes in Beneficial Ownership (4)
10/16/201916:03EDGARProxy Statement - Notice of Shareholders Meeting..
10/10/201916:02EDGARCurrent Report Filing (8-k)
10/10/201908:30PRNUSAmpio Provides Update on Continued Progress of AP-013 Phase..
See more news about this stock »

Your Recent History
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.